Save up -80% on Aclidinium

Note: this is a drug discount program, not an insurance plan.

RX BIN: 015558
RX PCN: HT
Group ID: DDN6600
Card Holder ID: DDN6600

Pharmacists and Patients support.

2018 Price of Tudorza Pressair

$157

1 inhaler (30 doses)

* price without discount in nearest pharmacy. Price may vary.

Claim your free Aclidinium discount card

We offer free Aclidinium coupons and discounts that may help you save up to 80% off the retail price in your local pharmacy. Just print your coupon! It’s ready to use and never expire. Present your discount card in most local pharmacies to get a discount on Aclidinium every time. What are you waiting for? Claim your prescription drug card now!

Get your Prescription
It’s safe and free
Buy drugs in pharmacy
Save money each time

Aclidinium volume of distribution

Following IV administration, the volume of distribution is 300 L

About RX24Drugs

Discount Cards 16,000+

Clients Benefit 29%

Total savings $4,735,080

What is Aclidinium

Aclidinium is an anticholinergic for the long-term management of chronic obstructive pulmonary disease (COPD). It has a much higher propensity to bind to muscarinic receptors than nicotinic receptors. FDA approved on July 24, 2012.

Aclidinium mechanism of action

Aclidinium is a long-acting, competitive, and reversible anticholinergic drug that is specific for the acetylcholine muscarinic receptors. It binds to all 5 muscarinic receptor subtypes to a similar affinity. Aclidinium’s effects on the airways are mediated through the M3 receptor at the smooth muscle to cause bronchodilation. Prevention of acetylcholine-induced bronchoconstriction effects was dose-dependent and lasted longer than 24 hours.

Dosage forms of Aclidinium

DrugDosageQuantityPrice
Tudorza Pressair400mcg1 inhaler (30 doses)$157.80
Tudorza Pressair400mcg3 inhalers (30 doses)$486.94
Tudorza Pressair400mcg1 inhaler (60 doses)$313.27
Tudorza Pressair400mcg30 inhalers (60 doses)$9,343
Prescription Generics

false

International Brands

Duaklir Genuair

Synonyms

Aclidinium

Manufacturers

Astrazeneca Canada Inc

CAS number

727649-81-2

UNII

K17VY42F6C

State

solid

Affected organisms

Humans and other mammals

Indication of Aclidinium

Aclidinium bromide inhalation powder is indicated for the long-term, maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.

Toxicity of Aclidinium

Most common adverse reactions ( 3% incidence and greater than placebo) are headache, nasopharyngitis and cough.

RX24 Drugs Disclaimer: before buying a Aclidinium on prescription, consult your healthcare provider. Content on this page is provided for informational purposes only. Any use of this information is at your own risk.

Get lower price on Aclidinium now!